MediPharm Labs is entering a new international market. The company signed a supply agreement. This deal is with Remidose Aerosols Inc. It will bring GMP-certified cannabis products to Costa Rica. This move marks a significant step for MediPharm’s global strategy. It also supports patients in a growing medical cannabis market. This news is creating buzz…
Ukraine has approved new quotas. This is for medical cannabis production. It covers the year 2026. This marks a significant step. It is the first time such quotas are set. The government now regulates cannabis use. This is for medical, scientific, and industrial purposes. This news follows recent legalization efforts. These events are unfolding rapidly….
California’s cannabis industry shows new life. The market faced tough times recently. Now, major deals signal a fresh start. Optimism is trending for the new year. Several significant events are driving this shift. These news items paint a promising picture. Vireo Growth Acquires Eaze Vireo Growth Inc. made a big move. It acquired cannabis delivery…
New laws are now in effect. They impact cannabis and hemp markets. This change occurred on January 1, 2026. Several states are enacting stricter rules. These regulations aim for tighter oversight. They cover state marijuana programs. The hemp-derived product market also faces changes. This is a trending development. It marks a new chapter for the…
2026 Cannabis Events Calendar: Trending Industry News & Networking Opportunities The cannabis industry is buzzing. A busy year of cannabis events is ahead in 2026. Many key gatherings will shape industry trends. CelebStoner’s guide highlights these important dates. It offers a roadmap for professionals. The events promise valuable news and connections. January 2026 Kicks Off…
Federal Rescheduling Ignites Cannabis Real Estate Momentum The cannabis real estate market is experiencing a surge in activity. This momentum follows a significant federal policy shift. President Trump’s executive order reclassified marijuana. This change is effective December 30, 2025. Marijuana is now designated a Schedule III drug. This federal recognition removes major barriers for the…
The year 2025 marked a pivotal moment for the cannabis industry. Major policy changes and evolving consumer trends reshaped the landscape. Federal and state governments made significant moves. These developments set the stage for continued growth and transformation. Federal Rescheduling Marks a New Era President Donald Trump signed a landmark executive order. This occurred on…
Marijuana Rescheduling to Schedule III: Economic Hopes Clash with Health Risks A pivotal move is underway. President Trump has directed the expedited reclassification of marijuana. It will move from Schedule I to Schedule III under the Controlled Substances Act. This federal policy shift is significant. It has generated considerable discussion. Reactions are varied across the…
A historic shift is underway. The federal government is moving marijuana. It moves from Schedule I to Schedule III. This change impacts many sectors. It brings both opportunity and uncertainty. This significant news is trending nationwide. Background to the Rescheduling For over 50 years, marijuana was a Schedule I substance. This placed it with drugs…
President Trump signed a new Executive Order on December 18, 2025. This order aims to speed up cannabis research. It directs the Attorney General to expedite rescheduling. Cannabis is moving from Schedule I to Schedule III. This is a major shift in federal policy. For years, Schedule I status blocked research. Schedule I drugs have…
